Evidence map›Paper›PMID 38927543›Full record

ArticleBiomedicines2024

The Endothelial Glycocalyx in Pig-to-Baboon Cardiac Xenotransplantation-First Insights.

Martin Bender, Jan-Michael Abicht, Bruno Reichart, Maria Leuschen, Felicia Wall, Julia Radan, Elisabeth Neumann, Maren Mokelke, Ines Buttgereit, Sebastian Michel and 14 more

Abstract read
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Progress in Orthotopic Pig Heart Transplantation in Nonhuman Primates.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Martin BenderDepartment of Anaesthesiology, University Hospital, LMU Munich, 81377 Munich, Germany.ORCID 0000-0002-9590-4728
Jan-Michael AbichtDepartment of Anaesthesiology, University Hospital, LMU Munich, 81377 Munich, Germany.
Bruno ReichartTransregional Collaborative Research Center 127, Walter Brendel Centre of Experimental Medicine, LMU Munich, 81377 Munich, Germany.
Maria LeuschenTransregional Collaborative Research Center 127, Walter Brendel Centre of Experimental Medicine, LMU Munich, 81377 Munich, Germany.
Felicia WallTransregional Collaborative Research Center 127, Walter Brendel Centre of Experimental Medicine, LMU Munich, 81377 Munich, Germany.
Julia RadanTransregional Collaborative Research Center 127, Walter Brendel Centre of Experimental Medicine, LMU Munich, 81377 Munich, Germany.
Elisabeth NeumannTransregional Collaborative Research Center 127, Walter Brendel Centre of Experimental Medicine, LMU Munich, 81377 Munich, Germany.
Maren MokelkeTransregional Collaborative Research Center 127, Walter Brendel Centre of Experimental Medicine, LMU Munich, 81377 Munich, Germany.
Ines ButtgereitDepartment of Anaesthesiology, University Hospital, LMU Munich, 81377 Munich, Germany.
Sebastian MichelDepartment of Cardiac Surgery, University Hospital, LMU Munich, 81377 Munich, Germany.
Reinhard EllgassDepartment of Cardiac Surgery, University Hospital, LMU Munich, 81377 Munich, Germany.
Katja GiesekeDepartment of Anaesthesiology, University Hospital, LMU Munich, 81377 Munich, Germany.
Stig SteenDepartment of Cardiothoracic Surgery, Lund University and Skåne University Hospital, 221 85 Lund, Sweden.
Audrius PaskeviciusDepartment of Cardiothoracic Surgery, Lund University and Skåne University Hospital, 221 85 Lund, Sweden.
Joachim DennerInstitute of Virology, Free University Berlin, 14163 Berlin, Germany.ORCID 0000-0003-3244-6085
Antonia W GodehardtDivision of Haematology, Cell and Gene Therapy, Paul-Ehrlich-Institut, 63225 Langen, Germany.ORCID 0000-0001-8014-5530
Ralf R TönjesDivision of Haematology, Cell and Gene Therapy, Paul-Ehrlich-Institut, 63225 Langen, Germany.ORCID 0000-0001-8727-1935
Christian HaglDepartment of Cardiac Surgery, University Hospital, LMU Munich, 81377 Munich, Germany.
David AyaresRevivicor, Blacksburg, VA 24060, USA.
Eckhard WolfInstitute of Molecular Animal Breeding and Biotechnology, Gene Center, and Department of Veterinary Sciences, LMU Munich, 81377 Munich, Germany.ORCID 0000-0002-0430-9510
Michael SchmoeckelDepartment of Cardiac Surgery, University Hospital, LMU Munich, 81377 Munich, Germany.ORCID 0009-0005-2399-2836
Paolo BrennerDepartment of Cardiac Surgery, University Hospital, LMU Munich, 81377 Munich, Germany.
Martin B MüllerDepartment of Anaesthesiology, University Hospital, LMU Munich, 81377 Munich, Germany.
Matthias LänginDepartment of Anaesthesiology, University Hospital, LMU Munich, 81377 Munich, Germany.

Funding

Nonhuman Primate Reagent ResourceU24AI126683 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2016 to 2026
$20.1M
Bavarian Research Foundation AZ-1543-22Deutsche Forschungsgemeinschaft TRR 127Fondation Leducq 23CVD01NIAID NIH HHS U24 AI126683Swiss National Science Foundation CR-SII5_198577
6 · The paper itself

Abstract

Cardiac xenotransplantation has seen remarkable success in recent years and is emerging as the most promising alternative to human cardiac allotransplantation. Despite these achievements, acute vascular rejection still presents a challenge for long-term xenograft acceptance and new insights into innate and adaptive immune responses as well as detailed characterizations of signaling pathways are necessary. In allotransplantation, endothelial cells and their sugar-rich surface-the endothelial glycocalyx-are known to influence organ rejection. In xenotransplantation, however, only in vitro data exist on the role of the endothelial glycocalyx so far. Thus, in the current study, we analyzed the changes of the endothelial glycocalyx components hyaluronan, heparan sulfate and syndecan-1 after pig-to-baboon cardiac xenotransplantations in the perioperative (n = 4) and postoperative (n = 5) periods. These analyses provide first insights into changes of the endothelial glycocalyx after pig-to-baboon cardiac xenotransplantation and show that damage to the endothelial glycocalyx seems to be comparable or even less pronounced than in similar human settings when current strategies of cardiac xenotransplantation are applied. At the same time, data from the experiments where current strategies, like non-ischemic preservation, growth inhibition or porcine cytomegalovirus (a porcine roseolovirus (PCMV/PRV)) elimination could not be applied indicate that damage of the endothelial glycocalyx also plays an important role in cardiac xenotransplantation.

Indexed as

endothelial activationendothelial glycocalyxheartorgan preservationorthotopic heart transplantationxenotransplantation

Identifiers

PMID38927543
PMCPMC11201800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.